The Cigna Group reported second-quarter 2025 revenue of $67.2 billion, an 11% increase year-over-year, surpassing Wall Street estimates. Adjusted income from operations for the quarter was $7.20 per share, slightly exceeding consensus expectations, driven by robust performance in its Evernorth Health Services segment.
Despite the strong revenue growth, net income for the second quarter was $1.53 billion, or $5.71 per share, indicating a flat performance compared to the prior year. This was influenced by persistently heightened medical costs, which continue to be a factor in the healthcare industry.
Evernorth Health Services was a primary driver of the revenue surge, with its pharmacy benefit management business demonstrating significant strength. Cigna's health insurance business performed within expectations, navigating the elevated medical cost environment. The company's ability to grow revenue while managing cost pressures remains a key focus for investors.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.